Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 30/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

50%

3 of 6 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

Phase 3

3(42.9%)

N/A

2(28.6%)

Phase 1

1(14.3%)

Phase 2

1(14.3%)

7Total

Phase 3(3)

N/A(2)

Phase 1(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04233424Phase 3Completed

D-PLEX 311: Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection

Role: lead

NCT02731573Phase 1Completed

Safety and Efficacy of D-PLEX in the Prevention of Sternal Infection Post Cardiac Surgery.

Role: lead

NCT03633123Phase 2Completed

D-PLEX 310: Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection

Role: lead

NCT04411199Phase 3Completed

D-PLEX 312 - Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection (SHIELD II)

Role: lead

NCT03558984Phase 3Terminated

D-PLEX 302: Efficacy and Safety of D-PLEX in the Prevention of Sternal Infection Post Cardiac Surgery

Role: lead

NCT02491047Not ApplicableCompleted

Safety and Performance of BonyPid-1000™ in the Treatment of Gustilo I, II, IIIA and IIIB Tibial Open Fractures

Role: lead

NCT02531100Not ApplicableCompleted

BonyPid-500TM Bone Graft Substitute Study

Role: lead

All 7 trials loaded